Delivery Order SPE2DB24D1205-SPE2DB24FCUCZ
Award Date
8/27/24
Potential Completion Date
8/28/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for the supply of the pharmaceutical product XCOPRI 150 mg Tablet 30s, with a ceiling value of $1,615.12 and a performance period through May 15, 2025. The contract is a firm-fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the drug XCOPRI 50 MG TABLET 30S. The contract has a ceiling value of $1,082.68 and a period of performance ending on July 2, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,768.44 and covers the delivery of the prescription medication XCOPRI 150 MG TABLET 30S. The contract has an ultimate completion date of May 2, 2025. This contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XCOPRI 100 MG TABLET 30S. The contract has a ceiling value of $1,889.05 and a completion date of July 7, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S, with a potential value of $1,082.68 and a completion date of February 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 200 MG TABLET 30S, a specialty pharmaceutical product, with a ceiling value of $2,357.92 and a completion date of November 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of XCOPRI 50 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $2,420.16 and an ultimate completion date of July 2, 2025. It is a firm fixed-price contract, indicating the price is set and will not change. The contract is not designated as a set-aside, meaning it was open to all qualified...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication XCOPRI 200 MG TABLET 30S. The contract has a ceiling value of $2,354.89 and a completion date of July 5, 2023. It is a firm fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication XCOPRI 200 MG TABLET 30S. The contract has a ceiling value of $1,767.72 and is a firm fixed-price delivery order, with a period of performance through May 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,768.44 and a completion date of May 13, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...